Description
20/20 GeneSystems Inc., a clinical laboratory testing company, develops and commercializes artificial intelligence powered cancer screenings tests for the earlier detection of multiple cancers. It offers OneTest, a multi-cancer screening test to identify types cancer, including lung, liver, and pancreas; PAULA's Test, a blood test for the early detection of lung cancer; BioCheck, a suspicious powder screening kit that provides a screening tool to determine whether a powder contains biological material to check common substances that cause powder incidents; and CoronaCheck Tests, a suite of Covid-19 detection tests. The company was formerly known as 20/20 Gene Systems, Inc. and changed its name to 20/20 GeneSystems Inc. in June 2001. 20/20 GeneSystems Inc. was incorporated in 2000 and is based in Rockville, Maryland.
